Cargando…

Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry

High-molecular weight aggregates such as antibody dimers and other side products derived from incorrect light or heavy chain association typically represent critical product-related impurities for bispecific antibody formats. In this study, an approach employing ultra-pressure liquid chromatography...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haberger, Markus, Leiss, Michael, Heidenreich, Anna-Katharina, Pester, Oxana, Hafenmair, Georg, Hook, Michaela, Bonnington, Lea, Wegele, Harald, Haindl, Markus, Reusch, Dietmar, Bulau, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966600/ https://www.ncbi.nlm.nih.gov/pubmed/26655595 http://dx.doi.org/10.1080/19420862.2015.1122150

Ejemplares similares

Functional assessment of antibody oxidation by native mass spectrometry
por: Haberger, Markus, et al.
Publicado: (2015)

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods
por: Reusch, Dietmar, et al.
Publicado: (2015)

Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation
por: Falck, David, et al.
Publicado: (2017)

Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry
por: Lippold, Steffen, et al.
Publicado: (2019)

Identification of Hetero-aggregates in Antibody Co-formulations by Multi-dimensional Liquid Chromatography Coupled to Mass Spectrometry
por: Kuhne, Felix, et al.
Publicado: (2023)

Affinity Capillary Electrophoresis–Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody–Receptor Interactions
por: Gstöttner, Christoph, et al.
Publicado: (2021)

Size-Exclusion Chromatography for the Analysis of Protein Biotherapeutics and their Aggregates
por: Hong, Paula, et al.
Publicado: (2012)

The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange
por: Kuhne, Felix, et al.
Publicado: (2019)

Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody
por: Cramer, Dario A. T., et al.
Publicado: (2023)

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 1: Separation-based methods
por: Reusch, Dietmar, et al.
Publicado: (2014)

Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants
por: Čaval, Tomislav, et al.
Publicado: (2021)

Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions
por: Schmid, Ingrid, et al.
Publicado: (2018)

Comprehensive Multidimensional Liquid Chromatography–Mass Spectrometry for the Characterization of Charge Variants of a Bispecific Antibody
por: Grunert, Ingrid, et al.
Publicado: (2022)

Rapid Analysis of Biotherapeutics Using Protein A Chromatography Coupled to Orbitrap Mass Spectrometry
por: Jakes, Craig, et al.
Publicado: (2021)

Probing Protein Denaturation during Size-Exclusion Chromatography Using Native Mass Spectrometry
por: Ventouri, Iro K., et al.
Publicado: (2020)

Identification and Monitoring of Host Cell Proteins by Mass Spectrometry Combined with High Performance Immunochemistry Testing
por: Bomans, Katrin, et al.
Publicado: (2013)

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
por: Haberger, Markus, et al.
Publicado: (2014)

A Universal Eluent System for Method Scouting and Separation of Biotherapeutic Proteins by Ion-Exchange, Size-Exclusion, and Hydrophobic Interaction Chromatography
por: Schwahn, Alexander B., et al.
Publicado: (2022)

Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability
por: Grunert, Ingrid, et al.
Publicado: (2022)

Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry
por: Gstöttner, Christoph, et al.
Publicado: (2019)

Simultaneous Monitoring of Monoclonal Antibody Variants by Strong Cation-Exchange Chromatography Hyphenated to Mass Spectrometry to Assess Quality Attributes of Rituximab-Based Biotherapeutics
por: Di Marco, Fiammetta, et al.
Publicado: (2021)

Development of a Liquid Chromatography and High-Resolution and -Accuracy Mass Spectrometry Method to Evaluate New Biotherapeutic Entity Processing in Human Liver Lysosomes
por: Colangelo, Gabriele Sergio, et al.
Publicado: (2023)

Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approach
por: Hajduk, Joanna, et al.
Publicado: (2020)

Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25
por: Enko, Dietmar, et al.
Publicado: (2019)

An evaluation of instrument types for mass spectrometry-based multi-attribute analysis of biotherapeutics
por: Zhang, Zhongqi, et al.
Publicado: (2020)

Mass spectrometry data and size exclusion chromatography profiles of Australian taipan venom toxins
por: Harrison, Julian A., et al.
Publicado: (2016)

Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice
por: Enko, Dietmar, et al.
Publicado: (2021)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products
por: Murisier, Amarande, et al.
Publicado: (2022)

Native size-exclusion chromatography-mass spectrometry: suitability for antibody–drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels
por: Jones, Jay, et al.
Publicado: (2019)

Native Size-Exclusion Chromatography–Based Mass Spectrometry Reveals New Components of the Early Heat Shock Protein 90 Inhibition Response Among Limited Global Changes
por: Samant, Rahul S., et al.
Publicado: (2022)

Development of a two-dimensional liquid chromatography-tandem mass-spectrometry method for the determination of vitamin D2 in mushrooms
por: Zelzer, Sieglinde, et al.
Publicado: (2022)

Strategies in size-exclusion chromatography /
Publicado: (1996)

Native Liquid Chromatography and Mass Spectrometry to Structurally and Functionally Characterize Endo-Xylanase Proteoforms
por: van Schaick, Guusje, et al.
Publicado: (2022)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023)

Comparative Analysis of Antibodies and Heavily Glycosylated Macromolecular Immune Complexes by Size-Exclusion Chromatography Multi-Angle Light Scattering, Native Charge Detection Mass Spectrometry, and Mass Photometry
por: den Boer, Maurits A., et al.
Publicado: (2021)

Reversed Phase-Liquid Chromatography for Recombinant AAV Genome Integrity Assessment
por: Gstöttner, Christoph, et al.
Publicado: (2023)

Modern trends in downstream processing of biotherapeutics through continuous chromatography: The potential of Multicolumn Countercurrent Solvent Gradient Purification
por: De Luca, Chiara, et al.
Publicado: (2020)

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry
por: Lippold, Steffen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn5lo1pb6q4nti3g16rvgfbk22